CDSCO UID IMP/IVD/2019/000113_43f820ee9024b6f081e8d9bd085d3bb9_9756f8ca509b40695486b4b057d77831LIAISON fPSA
- UID
- IMP/IVD/2019/000113_43f820ee9024b6f081e8d9bd085d3bb9_9756f8ca509b40695486b4b057d77831
- Device class
- Class C
- Brand name
- LIAISON fPSA
- License holder
- Diasorin Healthcare India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- In vitro assay for the quantitative determination of free human prostate-specific antigen (LIAISON fPSA) in human serum and plasma (LIAISON fPSA). The test has to be performed on the LIAISON® Analyzer family
LIAISON fPSA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000113_43f820ee9024b6f081e8d9bd085d3bb9_9756f8ca509b40695486b4b057d77831. This device is marketed under the brand name LIAISON fPSA. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.